Biotech Takeover Targets Wall Street Eyes After Apogee Deal
AbbVie’s Apogee deal has revived takeover chatter. Three Nasdaq-listed biotech players are emerging as plausible biot...
A quick guide to reputable sources for index level data, plus tips on choosing datasets and validating their reliability for analysis.
24,978 articlesAbbVie’s Apogee deal has revived takeover chatter. Three Nasdaq-listed biotech players are emerging as plausible biot...
Real estate firms lean on AI-powered ads and social media to attract buyers and sellers as 2026 data shows shifting o...
Meta is weighing a bold bet to embed real-money wagering in its social apps. The move could unlock new revenue but ra...
Public disclosures show surprising activity in major names, but smart investing hinges on fundamentals, risk, and a d...
Oracle just fresh 52-week lows as a credit downgrade highlights the tension between expensive AI infrastructure and c...
Russia is moving to block foreign crypto exchanges unless they comply with new domestic regulations, aiming to funnel...
A major investment manager has built a sizable position in CCC Intelligent Solutions with a $15 million purchase. Thi...
AI misinfo is not just a tech issue—it's a real-world risk that can touch markets, portfolios, and lives. This articl...
A veteran strategist warns that the odds stock market meltdown could jump to 35% this year as oil shocks and sluggish...
The U.S. government withdraws a global AI chip licensing plan, removing near-term constraints on Nvidia's internation...
Oracle is sitting on a massive backlog that could redefine its AI trajectory in 2026. This deep dive breaks down what...
The Federal Reserve keeps rates unchanged as Powell's tenure nears its end, citing inflation risks and global tension...